A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers
Stopped Funding
Conditions
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- Oral Cavity Squamous Cell Carcinoma
- Oral Cavity Cancer
- Oropharynx Cancer
- Oropharynx Squamous Cell Carcinoma
- Larynx Cancer
- Pharynx Cancer
- Hypopharynx Cancer
- Hypopharynx Squamous Cell Carcinoma
Interventions
- DRUG: Zimberelimab
- DRUG: Etrumadenant
- DRUG: Cisplatin
- RADIATION: Radiation
Sponsor
Jennifer Choe
Collaborators